Top News

Eli Lilly signage on a pharmaceutical company building with a US flag above

INNOVATION

9 Jan 2026

The Race to Replace Needles With Pills Gets Smarter

AI-powered collaborations are speeding oral obesity and diabetes drugs, promising easier dosing and a faster path from discovery to market

MARKET TRENDS

22 Jan 2026

GLP-1 Drugs Get Cheaper and More Consumer-Friendly

Pre-filled GLP-1 injection pens used in obesity and metabolic disease treatment

REGULATORY

15 Jan 2026

FDA Reasserts Limits as GLP-1 Shortages Fade

Latest News

RESEARCH
27 Feb 2026
Can AI Crack the Code on Fibrosis?
INNOVATION
25 Feb 2026
AI Unlocks the Secret to Cell Entry
PARTNERSHIPS
24 Feb 2026
U.S. Peptide Groups Form GMP Alliance
INVESTMENT
23 Feb 2026
$305mn Bet on Peptides Signals Shift in Cancer

AI-Designed Peptide Enters Late-Stage Infection Trial

White pills and capsule with thermometer on dollar notes

INNOVATION

20 Feb 2026

Peptilogics advances zaloganan into Phase 2/3 with $120mn in funding to tackle biofilm-related joint infections

MARKET TRENDS

22 Apr 2025

Merck’s $493M Pill Bet Aims to Replace Injections

Merck and Cyprumed sign licensing deal to turn injectables into pills, highlighting a shift toward easier, patient-friendly drug formats.

INNOVATION

14 Mar 2025

Cancer’s New Opponent: SYNB011128

SYNB011128’s dual-target design signals a leap in smart cancer drug delivery.

Person wearing a peptide delivery patch on arm.

INNOVATION

8 Mar 2025

No Needles, No Problem: Peptide Patches Take Off

Kindeva and Vaxxas advance needle-free delivery for peptides, with implications for chronic disease treatment and global health access

8 9

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.